Affordable Access

Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial.

Authors
Type
Published Article
Journal
The Lancet Oncology
1470-2045
Publisher
Elsevier
Publication Date
Volume
7
Issue
1
Pages
43–51
Identifiers
PMID: 16389183
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments